Q3 Results | ALNY Message Board Posts


Alnylam Pharmaceuticals

  ALNY website

ALNY   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  35104 of 35110  at  10/27/2022 10:18:23 AM  by

Steve_382


Q3 Results

 FWIW, this is a pic of my product revenue table. Yellow highlights are still estimates. Notably, Onpattro patients are starting to move to Amvuttra. Leqvio is still just my guess on the numbers, but NVS reported $34M in sales, so that's about 10,000 patients. Givlaari was basically flat Q/Q. No guarantees on the numbers, but I tried.
 
 
 


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 1  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board




Financial Market Data provided by
.
Loading...